1102 / 1138
Starting your SABR program
•
True improvements arising from local treatments are
uncommon, and healthcare costs are important (cost-
benefit ratio)
•
Avoid over-promising and under-delivering (e.g. proton
therapy …
)
•
Developments in competing ablative therapies (RFA,
Nanoknife® Irreversible Electroporation)